歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Apoptosis > MK-4827 (Niraparib)

瀏覽歷史

S80048

MK-4827 (Niraparib)

源葉(MedMol) 99%
  • 英文名:
  • MK-4827 (Niraparib)
  • 別名:
  • 2-[4-((3S)-3-哌啶基)苯基]-2H-吲唑-7-甲酰胺;(S)-2-(4-(哌啶-3-基)苯基)-2H-吲唑-7-羧酰胺;MK4827; 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide;
  • CAS號(hào):
  • 1038915-60-4
  • 分子式:
  • C19H20N4O
  • 分子量:
  • 320.39
  • 核磁/質(zhì)譜:
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車...
源葉(MedMol) S80048-1mg 99% ¥217.60元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80048-2mg 99% ¥306.00元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80048-5mg 99% ¥408.00元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80048-10mg 99% ¥605.20元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80048-25mg 99% ¥816.00元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80048-50mg 99% ¥1156.00元 >10 - - - EA 加入購(gòu)物車
源葉(MedMol) S80048-100mg 99% ¥2176.00元 >10 - - - EA 加入購(gòu)物車
大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity
  • 靶點(diǎn): PARP-2:2.1 nM (IC50);PARP-1:3.8 nM (IC50);V-PARP:330 nM (IC50);TANK-1:570 nM (IC50);PARP-3:1300 nM (IC50);Apoptosis;PARP
  • 體內(nèi)研究:
    Niraparib (MK-4827) is well tolerated and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer. Niraparib (MK-4827) is well tolerated in vivo and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer. Niraparib (MK-4827) is characterized by acceptable pharmacokinetics in rats with plasma clearance of 28 (mL/min)/kg, very high volume of distribution (Vdss=6.9 L/kg), long terminal half-life (t1/2=3.4 h), and excellent bioavailability, F=65%. Niraparib (MK-4827) enhances radiation response of p53 mutant Calu-6 tumor in both cases, with the single daily dose of 50 mg/kg being more effective than 25 mg/kg given twice daily
  • 參考文獻(xiàn):
    1. Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85. 2. Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86. 3. Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20. 4. Mirza MR, et al. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. N Engl J Med. 2016 Dec 1;375(22):2154-2164.
  • 溶解性: DMSO  :  25  mg/mL  (78.03  mM;  Need  ultrasonic)H2O  :  <  0.1  mg/mL  (ultrasonic;warming;heat  to  80°C)  (insoluble)
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 3.121 ml 15.606 ml 31.212 ml
    5 mM 0.624 ml 3.121 ml 6.242 ml
    10 mM 0.312 ml 1.561 ml 3.121 ml
    50 mM 0.062 ml 0.312 ml 0.624 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。